In a significant leadership reshuffle, Roswell Park Comprehensive Cancer Center has announced the appointment of Julia Faller, DO, as its new chief medical officer alongside promotions within four crucial departments. The announcement made on February 29 marks a pivotal moment for the center, emphasizing its commitment to advancing cancer care and research.
Strategic Leadership Appointments
Dr. Julia Faller, who has been a part of Roswell Park since 2009 and recently served as chief of perioperative services, steps into the role of chief medical officer with a wealth of experience. Alongside her, Aleodor “Doru” Andea, MD, takes on the role of chief of dermatopathology and director of molecular dermatopathology. This department plays a critical role in the microscopic and molecular level study of skin diseases. Kenan Onel, PhD, MD, has been appointed as chief of clinical genomics and founding director of the center for precision oncology, a department poised to revolutionize cancer treatment through precision medicine.
Moreover, Jenny Romero, MD, becomes the chief of head and neck/plastic and reconstructive surgery and general medical oncology, highlighting the center’s focus on comprehensive care. Lastly, Zhongbo “Jerry” Yang, MD, steps into the chief role for cytopathology, emphasizing the importance of advanced diagnostic tools in cancer treatment. These appointments underscore Roswell Park’s dedication to leadership in cancer care and research.
Advancing Precision Oncology
The significance of these appointments is further highlighted by the advancements in cancer genomics and precision oncology. Recent developments in cancer genomics have shown promising results in understanding and treating cancer more effectively. Technologies such as artificial intelligence, liquid biopsy analyses, optical genome mapping, and sequencing technologies are at the forefront of this revolution. Companies like Tempus and…
Read the full article here
